English
This article is from The Indian Journal of Medical Research , volume 134 . Abstract Among the aetiological agents of treatable sexually transmitted diseases (STDs), Neissseria gonorrhoeae is considered to be most important because of emerging antibiotic resistant strains that compromise the effectiveness of treatment of the disease - gonorrhoea. In most of the developing countries, treatment of gonorrhoea relies mainly on syndromic management rather than the aetiological based therapy. Gonococcal infections are usually treated with single-dose therapy with an agent found to cure > 95 per cent of cases. Unfortunately during the last few decades, N. gonorrhoeae has developed resistance not only to less expensive antimicrobials such as sulphonamides, penicillin and tetracyclines but also to fluoroquinolones. The resistance trend of N. gonorrhoeae towards these antimicrobials can be categorised into pre-quinolone, quinolone and post-quinolone era. Among the antimicrobials available so far, only the third-generation cephalosporins could be safely recommended as first-line therapy for gonorrhoea globally. However, resistance to oral third-generation cephalosporins has also started emergi
Sign in with your free account to read, download EPUBs or listen.
Ebook · An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae. · Patel, Achchhe Lal, Chaudhry, Uma, Sachdev, Divya, Sachdeva, Poonam Nagpal, Bala, Manju, Saluja, Daman · Internet Archive